In the rapidly evolving world of biopharmaceuticals, China has emerged as an unexpected yet strategic battleground for the development and testing of weight loss drugs. Despite its relatively low obesity rate, the nation’s burgeoning population of overweight individuals is fueling a market ripe for obesity interventions, poised to redefine the healthcare landscape in China and […]
